[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2402447A1 - Procede et ampoule pour la preparation de produits pharmaceutiques radioactifs - Google Patents

Procede et ampoule pour la preparation de produits pharmaceutiques radioactifs

Info

Publication number
FR2402447A1
FR2402447A1 FR7825759A FR7825759A FR2402447A1 FR 2402447 A1 FR2402447 A1 FR 2402447A1 FR 7825759 A FR7825759 A FR 7825759A FR 7825759 A FR7825759 A FR 7825759A FR 2402447 A1 FR2402447 A1 FR 2402447A1
Authority
FR
France
Prior art keywords
ampoule
preparation
substance
pharmaceutical products
radioactive pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7825759A
Other languages
English (en)
Other versions
FR2402447B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICN Switzerland AG
Original Assignee
Solco Basel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solco Basel AG filed Critical Solco Basel AG
Publication of FR2402447A1 publication Critical patent/FR2402447A1/fr
Application granted granted Critical
Publication of FR2402447B1 publication Critical patent/FR2402447B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01C—AMMONIA; CYANOGEN; COMPOUNDS THEREOF
    • C01C3/00—Cyanogen; Compounds thereof
    • C01C3/08—Simple or complex cyanides of metals
    • C01C3/12—Simple or complex iron cyanides
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G19/00—Compounds of tin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/44—Alpha, beta or gamma radiation related properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Pour marquer au technétium-99m, en système hétérogène, des substances organiques ou minérales, on mélange une solution aqueuse de la substance, un pertechnétate et une suspension aqueuse de Sn2 Fe(CN)6 , Sn3 ØFd(CN)6õ2 SnS ou SnTe et l'on sépare de la phase solide la solution de la substance marquée, après achèvement de la réduction du pertechnétate. En particulier, l'agent réducteur peut être presenté en ampoules, sous forme lyophilisée ou adsorbée, le cas échéant ensemble avec la substance à marquer.
FR7825759A 1977-09-08 1978-09-07 Procede et ampoule pour la preparation de produits pharmaceutiques radioactifs Granted FR2402447A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1102777A CH630261A5 (de) 1977-09-08 1977-09-08 Verfahren und ampulle zur herstellung von radiopharmazeutika.

Publications (2)

Publication Number Publication Date
FR2402447A1 true FR2402447A1 (fr) 1979-04-06
FR2402447B1 FR2402447B1 (fr) 1983-01-21

Family

ID=4369298

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7825759A Granted FR2402447A1 (fr) 1977-09-08 1978-09-07 Procede et ampoule pour la preparation de produits pharmaceutiques radioactifs

Country Status (16)

Country Link
US (1) US4250161A (fr)
JP (1) JPS5452298A (fr)
AU (1) AU517648B2 (fr)
BE (1) BE870219A (fr)
CA (1) CA1108049A (fr)
CH (1) CH630261A5 (fr)
DE (1) DE2838753A1 (fr)
DK (1) DK395078A (fr)
ES (1) ES473146A1 (fr)
FI (1) FI782746A (fr)
FR (1) FR2402447A1 (fr)
GB (1) GB2006510B (fr)
IT (1) IT1160636B (fr)
NL (1) NL7809172A (fr)
NO (1) NO148624C (fr)
SE (1) SE7809327L (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7900964A (nl) * 1979-02-07 1980-08-11 Byk Mallinckrodt Cil Bv Nieuwe radioactief gemerkte aminen, werkwijze ter bereiding van de nieuwe verbindingen, alsmede diagnostische preparaten op basis van de nieuwe verbindingen.
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same
WO1985002604A1 (fr) * 1983-12-06 1985-06-20 The Royal Melbourne Hospital PREPARATION DE PRODUITS RADIOPHARMACEUTIQUES A BASE DE TECHNETIUM-99m/
US5312592A (en) * 1990-06-13 1994-05-17 Scanditronix Ab Disposable kit for preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2543349C2 (de) * 1975-09-29 1984-05-10 Henkel KGaA, 4000 Düsseldorf Preaparate zur herstellung von99m technetium-radiagnostica
US4071613A (en) * 1976-02-26 1978-01-31 Abbott Laboratories Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation
GB1535847A (en) * 1976-03-19 1978-12-13 Radiochemical Centre Ltd Technetium-99m labelled tin colloid for body scanning

Also Published As

Publication number Publication date
CA1108049A (fr) 1981-09-01
IT7869068A0 (it) 1978-09-07
NO782982L (no) 1979-03-09
JPS5452298A (en) 1979-04-24
NO148624C (no) 1983-11-16
AU517648B2 (en) 1981-08-13
FI782746A (fi) 1979-03-09
NL7809172A (nl) 1979-03-12
GB2006510B (en) 1982-03-17
SE7809327L (sv) 1979-03-09
US4250161A (en) 1981-02-10
DK395078A (da) 1979-03-09
DE2838753A1 (de) 1979-03-22
GB2006510A (en) 1979-05-02
FR2402447B1 (fr) 1983-01-21
ES473146A1 (es) 1979-04-16
AU3968078A (en) 1980-03-13
CH630261A5 (de) 1982-06-15
IT1160636B (it) 1987-03-11
BE870219A (fr) 1979-03-05
NO148624B (no) 1983-08-08

Similar Documents

Publication Publication Date Title
BE904547A (fr) Nouveaux medicaments a usage topique.
DZ2666A1 (fr) Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation.
BE1003093A3 (fr) Procede de preparation d'une composition pharmaceutique sous forme de microparticules.
OA08462A (fr) Composés hétérocycliques condensés azotés, procédés pour les séparer et composition pharmaceutique en contenant.
FR2424856A1 (fr) Cartouche a plusieurs contenus et appareil de prelevement dose des contenus de cette cartouche
FR2630912B1 (fr) Composition permettant d'administrer un medicament sous forme de gelules, d'une poudre ou d'un liquide
BE875217A (fr) Nouvelles oximes 0-substituees de l'acide 7-amino thiazolyl acetamido cephalosporanque, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
NL7413848A (nl) Werkwijze voor de bereiding van farmacologisch werkzame 1,2-benzisoxazoolderivaten en gevormd farmaceutisch preparaat, dat een dezer stoffen
FR2402447A1 (fr) Procede et ampoule pour la preparation de produits pharmaceutiques radioactifs
FR2430236A1 (fr) Composition reductrice et procede pour la preparation de composes marques au technetium-99m, et substances radiopharmaceutiques contenant ces composes
OA09190A (fr) "Procédés de préparation de dérivés d'acides benzocycloalcényl dihydroxy alcanoïques et de médicaments les contenant".
DZ2680A1 (fr) Dérivé de thiazolidinedione nouveau procédé pour sa préparation et composition pharmaceutique le contenant.
FR2333076A1 (fr) Granules d'agents d'ennoblissement pour textiles utilisables dans des bains organiques de solvants, et leur procede de preparation
FR2621587B1 (fr) Derives du dimethyl-2,2 chromene, procede pour leur preparation et composition pharmaceutiques les contenant
KR850000974A (ko) 액체 윤활제를 함유하는 약제학적 조성물의 제조방법
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
MELLANBY et al. The effect of the treatment of crude tetanus toxin with ganglioside cerebroside complex on sphincter paralysis in the rabbit’s eye
FR2399835A1 (fr) Procede de preparation de microcapsules contenant un produit pharmaceutique
PT65264B (fr) Procede pour la preparation d'une composition pharmaceutique contenant des composes organiques
BE904864A (fr) Derives de la quinoleine, leur procede de preparation et compositions pharmaceutiques les contenant.
WO1989004356A3 (fr) Procede ameliore pour eliminer des substances nocives contenues dans des sols
FR2469179A1 (fr) Composition pharmaceutique pour injection renfermant une penicilline
FR2549067B1 (fr) Derives estradieniques radioactifs marques au tritium, leur procede de preparation et leur application pour l'etude et le dosage radio-immunologique de steroides dans les fluides biologiques
BE902251A (fr) Nouvelles compositions pharmaceutiques ayant une activite antimicrobienne et procede pour leur preparation.
FR2430767A1 (fr) Nouvelles compositions pharmaceutiques a action hypotensive accrue

Legal Events

Date Code Title Description
ST Notification of lapse